PubMed Health⌕ Search

Biomedical subjects

Dawn Wilkins

Publications and source records attributed to Dawn Wilkins.

3 recordsLinked to original sources

The effect of normalization on microarray data analysis.

This paper contains a description of several common normalization methods used in microarray analysis, and compares the effect of these methods on microarray data. The importance of background subtraction is also addressed. The research focuses on three parts. The first uses three statistical methods: t-test, Wilcoxon signed rank test, and sign test to measure the difference between background subtracted data and nonbackground subtracted data. The second part of the study uses the same three statistical methods to compare whether data normalized with different normalization methods yield similar results. The third part of the study focuses on whether these differently normalized data will influence the result of gene selection (dimension reduction). The comparisons are done for several data sets to help identify similarity patterns. The conclusion of this study is that background subtraction can make a difference, especially for some data sets with poorer quality data. The choice of normalization method, for the most part, makes little difference in the sense that the methods produce similarly normalized data. But, based on the third part of analysis, we found that when gene selection is performed on these differently normalized data, somewhat different gene sets are obtained. Thus, the choice of normalization method will likely have some effect on the final analysis.

Oligonucleotide Array Sequence Analysis↗

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

Treatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept of tailoring the intensity of therapy to a patient's risk of relapse. To determine whether gene expression profiling could enhance risk assignment, we used oligonucleotide microarrays to analyze the pattern of genes expressed in leukemic blasts from 360 pediatric ALL patients. Distinct expression profiles identified each of the prognostically important leukemia subtypes, including T-ALL, E2A-PBX1, BCR-ABL, TEL-AML1, MLL rearrangement, and hyperdiploid >50 chromosomes. In addition, another ALL subgroup was identified based on its unique expression profile. Examination of the genes comprising the expression signatures provided important insights into the biology of these leukemia subgroups. Further, within some genetic subgroups, expression profiles identified those patients that would eventually fail therapy. Thus, the single platform of expression profiling should enhance the accurate risk stratification of pediatric ALL patients.

Algorithms↗